Progyny Inc (NASDAQ:PGNY) saw an uptick in trading volume on Monday . 1,230,822 shares traded hands during trading, an increase of 88% from the previous session’s volume of 653,173 shares.The stock last traded at $28.54 and had previously closed at $26.64.
PGNY has been the topic of a number of research reports. Citigroup initiated coverage on shares of Progyny in a report on Wednesday, November 27th. They issued a “buy” rating and a $30.00 price target on the stock. Piper Jaffray Companies began coverage on Progyny in a research note on Wednesday, November 27th. They issued an “overweight” rating and a $33.00 price objective for the company. Goldman Sachs Group began coverage on shares of Progyny in a report on Tuesday, November 19th. They set a “buy” rating and a $33.00 price target for the company. Svb Leerink assumed coverage on shares of Progyny in a research note on Tuesday, November 19th. They issued an “outperform” rating and a $28.00 price objective on the stock. Finally, JPMorgan Chase & Co. assumed coverage on shares of Progyny in a research note on Wednesday, November 27th. They issued an “overweight” rating and a $26.00 target price for the company. Six research analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus target price of $29.67.
In related news, insider Peter Anevski sold 20,000 shares of Progyny stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $45.20, for a total value of $904,000.00. Also, CEO David J. Schlanger sold 960,007 shares of Progyny stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $16.39, for a total transaction of $15,734,514.73. Insiders have sold 1,933,004 shares of company stock valued at $32,258,136 over the last 90 days.
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
See Also: What does a market perform rating mean?
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.